when intellia therapeutics submit bla for lonvo-z
before 2027
when intellia therapeutics submit bla for lonvo-z. Best Yes near 75¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 75¢ · Best No: 35¢ · 1 platform
- Kalshi: Yes 75¢ / No 35¢
LIVE
before 2027
Volume
$75
$0 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Jan 1, 2027
~200 days left
Category
Culture
Yes
75¢
Kalshi
No
35¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Jan 1, 2027, then the market resolves to Yes.
Market Details
ResolutionResolves Jan 1, 2027
Time Left200 days
Status● Active
CategoryCulture
Yes
75¢
Kalshi
Payout 1.3x
No
35¢
Kalshi
Payout 2.9x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In